Market
Cytokinetics, Incorporated
Buy
Sell
One time
USD
CYTK
≈
0.15346839
CYTK
$50
$150
$500
Pay with
Google Pay
Apple Pay
USD Account
1-2 business days • No fees
Credit/debit card
Instant •
2.99%
0% fee first 30 days
Market
Cytokinetics, Incorporated
Buy
Sell
One time
USD
CYTK
≈
0.15346839
CYTK
$50
$150
$500
Pay with
Google Pay
Apple Pay
USD Account
1-2 business days • No fees
Credit/debit card
Instant •
2.99%
0% fee first 30 days
| Time | Price | Change |
|---|---|---|
| Today | 0.00% | |
| 1 day | -$0.84 (0.96%) | |
| 1 week | +$0.40 (0.32%) | |
| 1 month | -$5.59 (7.10%) | |
| 1 year | -$11.79 (13.71%) |
Rank
#13391
All-time high
$90.00
-38.12%
All-time low
$59.74
8.32%
CYTK
$65.16
-0.96%
Cytokinetics is a biopharmaceutical company focused on cancer and cardiovascular disease treatment. Co.'s drug candidate, SB-715992, is a Phase II clinical trials program conducted by its partner GlaxoSmithKline and the National Cancer Institute.